| |
| |
|
| Insider
Information: |
Hill Emily Luisa |
| Relationship: |
Chief Financial Officer |
| City: |
South Plainfield |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
148,920 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,030,226 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
148,920 |
|
|
| Total
Value |
$2,030,226 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PTC Therapeutics, Inc. |
PTCT |
|
2023-03-27 |
38,925 |
|
0 |
Premium* |
|
|
Replimune Group Inc |
REPL |
Chief Financial Officer |
2024-04-01 |
109,995 |
2023-09-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REPL |
Replimune Group Inc |
Chief Financial Officer |
• – – |
2024-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,665 |
109,995 |
0 |
- |
|
| REPL |
Replimune Group Inc |
Chief Financial Officer |
• – – |
2023-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
83,330 |
83,330 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2023-03-27 |
4 |
AS |
$45.00 |
$331,335 |
D/D |
(7,363) |
38,925 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2023-01-31 |
4 |
S |
$45.63 |
$26,236 |
D/D |
(575) |
46,288 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2023-01-24 |
4 |
S |
$47.45 |
$10,582 |
D/D |
(223) |
46,863 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2023-01-11 |
4 |
S |
$44.36 |
$18,542 |
D/D |
(418) |
47,086 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2023-01-10 |
4 |
S |
$42.93 |
$21,338 |
D/D |
(497) |
47,504 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2023-01-09 |
4 |
S |
$41.66 |
$31,575 |
D/D |
(758) |
48,001 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
19,500 |
48,759 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2022-03-31 |
4 |
AS |
$37.78 |
$298,824 |
D/D |
(7,910) |
29,259 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-02-01 |
4 |
S |
$40.00 |
$22,121 |
D/D |
(553) |
37,169 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-01-25 |
4 |
S |
$39.31 |
$8,295 |
D/D |
(211) |
37,722 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
15,600 |
37,933 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-01-07 |
4 |
S |
$38.53 |
$30,820 |
D/D |
(800) |
22,333 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-01-04 |
4 |
S |
$41.16 |
$7,121 |
D/D |
(173) |
23,133 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-02-01 |
4 |
S |
$56.96 |
$30,813 |
D/D |
(541) |
23,306 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-01-25 |
4 |
S |
$62.05 |
$17,065 |
D/D |
(275) |
23,847 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-01-08 |
4 |
AS |
$69.75 |
$1,815,802 |
D/D |
(26,033) |
24,122 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-01-08 |
4 |
OE |
$11.23 |
$613,409 |
D/D |
26,033 |
33,400 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,800 |
24,122 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-01-05 |
4 |
S |
$62.37 |
$17,963 |
D/D |
(288) |
13,322 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-06-29 |
4 |
AS |
$52.50 |
$135,503 |
D/D |
(2,581) |
13,610 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
9,300 |
16,191 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-01-23 |
4 |
S |
$53.25 |
$17,572 |
D/D |
(330) |
6,891 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-01-07 |
4 |
S |
$49.62 |
$3,126 |
D/D |
(63) |
7,221 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
